Stock CYTO ALTAMIRA THERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Altamira Therapeutics Nasdaq

Equities

CYTO

BMG0360L2099

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-07 EDT 		5-day change 1st Jan Change
1.43 USD -4.03% Intraday chart for Altamira Therapeutics -6.54% -58.91%
05-16 Altamira Therapeutics Ltd. Elects Dominik Lysek as Member of Board of Directors CI
05-01 Altamira Therapeutics Ltd. Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ALTAMIRA THERAPEUTICS
Bio Therapeutic Drugs
-4.03%-6.54% - - - 3.2M - - -

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. CYTO Stock
  4. CYTO Stock
  5. Charts Altamira Therapeutics
  6. Comparison Chart